Every SEC Form 3/4/5 on record for this filer (CIK 1596336) — 5 issuers, 58 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| CTS | CTS CORP | Director | 2018-04-18 → 2025-11-10 | 11 | $99,593 |
| CLDI | Calidi Biotherapeutics, Inc. | Director · lapsed | 2024-01-04 → 2024-01-04 | 1 | — |
| SYNH | Syneos Health, Inc. | Director · lapsed | 2022-01-20 → 2023-09-28 | 5 | — |
| AMRN | AMARIN CORP PLC\UK | Director · lapsed | 2022-05-20 → 2022-06-29 | 3 | — |
| LLY | ELI LILLY & Co | SVP & President, Lilly Int'l · lapsed | 2015-11-23 → 2021-02-10 | 29 | −$18M |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
4 of 5 issuers are covered and open a security page; the rest are on file here only.